Top ten pharmaceutical firm Eli Lilly, which produces the world’s
best selling anti-depressant, Prozac, has promoted Stephen Whitehead to
the position of corporate affairs director for Europe.
He replaces Klaus Welzel, who has been appointed business development
director for Europe.
Based at the firm’s London office, Whitehead will lead a team of five
people, reporting to European president Bert van den Bergh.
Whitehead, who was previously Eli Lilly UK corporate affairs director,
joined the company in January 1998 from Grand Metropolitan, where he was
external affairs director for three years.
Part of his task is to persuade governments to meet the costs of
innovative new medicines - several, including the UK government, are
alarmed by the rising costs of new drugs, such as Viagra.
Whitehead’s brief is to ensure best practice is maintained for Eli Lilly
corporate affairs across Europe. It includes product communications and
also some internal communications.
He will establish a corporate affairs best practice network within the
company across Europe.
Whitehead will work closely with the agencies retained by Eli Lilly,
which include Cohn and Wolfe and Edelman PR Worldwide, who both handle
PR for prescription medicines.